An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women
Status:
Completed
Trial end date:
2015-05-14
Target enrollment:
Participant gender:
Summary
The primary objective of the study was to evaluate the effect of 12 months of treatment with
romosozumab compared with teriparatide on total hip bone mineral density (BMD) in
postmenopausal women with osteoporosis who were previously treated with bisphosphonate
therapy.